Chemotherapy means hair loss, nausea and vomiting for many cancer patients. The debilitating side effects of chemotherapy occur because chemotherapy drugs attack all fast-reproducing cells, not just cancer cells. As a result, the damage done from chemotherapy treatment to normal cells leads to hair loss, nausea and vomiting.

Ark Therapeutics, a london-based drug researcher of gene-based medicine, has developed a new drug, Scavidin, that when added to current chemotherapy treatments, will eliminate the devastating and disabling side effects of hair loss, nausea and vomiting. Ark Therapeutics claims Scavidin is so revolutionary in its ability to deliver chemotherapy drugs to the tumor, that only one-tenth of chemotherapy doses in standard use today will need to be administered in the future, when used in combination with Scavidin. Ark Therapeutics is seeking approval for clinical trials of Scavidin in combination with chemotherapy treatment. If the new drug proves it can do all the researchers claim, it will be one of the most significant breakthroughs in gene-based medicine for cancer patients who must undergo chemotherapy.